Preimplantation Genetic Testing Market Research Report - Global Forecast till 2027

Preimplantation Genetic Testing Market Growth, Trends and Size Analysis by Procedure (Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening), Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, LA Typing and others), Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late-Onset Genetic Disorders, Inherited Genetic Disease and others), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Product and Service (Reagents and Consumables, Instruments, Software and Services) - Global Forecast till 2027

ID: MRFR/HC/6649-HCR | February, 2021 | Region : Global

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

5.4 Pricing Analysis

Chapter 6. Global Preimplantation Genetic Testing Market, by Procedure

6.1 Introduction

6.2 Preimplantation Genetic Diagnosis (PGD)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Preimplantation Genetic Screening (PGS)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Preimplantation Genetic Testing Market, by Type

7.1 Introduction

7.2 Chromosomal Abnormalities

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 X-linked Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Embryo Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Aneuploidy Screening

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 HLA Typing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Preimplantation Genetic Testing Market, by Application

8.1 Introduction

8.2 Embryo HLA typing for stem cell therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 IVF Prognosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Late-Onset Genetic Disorders

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Inherited Genetic Disease

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Preimplantation Genetic Testing Market, by Technology

8.1 Introduction

8.2 Next-Generation Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Polymerase Chain Reaction

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Fluorescence in Situ Hybridization

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Comparative Genomic Hybridization

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Single-Nucleotide Polymorphism

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Preimplantation Genetic Testing Market, by Product and Service

8.1 Introduction

8.2 Reagents and Consumables

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Instruments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Software and Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Preimplantation Genetic Testing Market, by End User

9.1 Introduction

9.2 Maternity Centers & Fertility Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Hospitals and Diagnostic Labs

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Research Laboratories & Academic Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Preimplantation Genetic Testing Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Natera, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 CooperSurgical, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 F. Hoffmann-La Roche AG

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Illumina, Inc.

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 IGENOMIX

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Reprogenetics, LLC

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Genea Limited

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 PerkinElmer, Inc.

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Genesis Genetics Ltd.

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Quest Diagnostics Incorporated

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Thermo Fisher Scientific, Inc

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.12 Bioarrayn Genetics

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.13 Laboratory Corporation of America Holdings

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.14 California Pacific Medical Center

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.15 Reproductive Health Science Ltd

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.16 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Global Preimplantation Genetic Testing Market

Chapter 13 Appendix

LIST OF TABLES

Table 1 Preimplantation Genetic Testing Market Synopsis, 2020-2027

Table 2 Preimplantation Genetic Testing Market Estimates and Forecast, 2020-2027(US Million)

Table 3 Global Preimplantation Genetic Testing Market, by Region, 2020-2027(USD Million)

Table 4 Global Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 5 Global Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 6 Global Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 7 Global Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 8 Global Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 9 Global Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 10 North America: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(US Million)

Table 11 North America: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 12 North America: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 13 North America: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 14 North America: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 15 North America: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 16 US: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 17 US: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 18 US: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 19 US: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 20 US: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 21 US: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 22 Canada: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 23 Canada: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 24 Canada Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 25 Canada Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 26 Canada Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 27 Canada: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 28 South America: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 29 South America: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 30 South America: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 31 South America: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 32 South America: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 33 South America: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 34 Europe: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 35 Europe: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 36 Europe Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 37 Europe Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Million)

Table 38 Europe Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 39 Europe: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 40 Western Europe: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 41 Western Europe: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 42 Western Europe: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 43 Western Europe: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 44 Western Europe: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 45 Western Europe: Preimplantation Genetic Testing Market, by End User, 2020-2027(USD Million)

Table 46 Eastern Europe: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 47 Eastern Europe: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 48 Eastern Europe Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 49 Eastern Europe Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 50 Eastern Europe Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 51 Eastern Europe: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 52 Asia-Pacific: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 53 Asia-Pacific: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 54 Asia-Pacific: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 55 Asia-Pacific: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 56 Asia-Pacific: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 57 Asia-Pacific: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 58 Middle East & Africa: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 59 Middle East & Africa: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 60 Middle East & Africa: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 61 Middle East & Africa: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 62 Middle East & Africa: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 63 Middle East & Africa: Preimplantation Genetic Testing Market, End User, 2020-2027(UD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Preimplantation Genetic Testing Market

Figure 3 Market Dynamics for Global Preimplantation Genetic Testing Market

Figure 4 Preimplantation Genetic Testing Market Share, by Type, 2020

Figure 5 Preimplantation Genetic Testing Market Share, by Treatment, 2020

Figure 6 Preimplantation Genetic Testing Market Share, End User, 2020

Figure 7 Preimplantation Genetic Testing Market Share, by Region, 2020

Figure 8 North America: Preimplantation Genetic Testing Market Share, by Country, 2020

Figure 9 Europe: Preimplantation Genetic Testing Market Share, by Country, 2020

Figure 10 Asia-Pacific: Preimplantation Genetic Testing Market Share, by Country, 2020

Figure 11 Middle East & Africa: Preimplantation Genetic Testing Market Share, by Region, 2020

Figure 12 Preimplantation Genetic Testing Market: Company Share Analysis, 2020 (%)

Figure 13 Natera, Inc.: Key Financials

Figure 14 Natera, Inc.: Segmental Revenue

Figure 15 Natera, Inc.: Geographical Revenue

Figure 16 CooperSurgical, Inc.: Key Financials

Figure 17 CooperSurgical, Inc.: Segmental Revenue

Figure 18 CooperSurgical, Inc.: Geographical Revenue

Figure 19 F. Hoffmann-La Roche AG: Key Financials

Figure 20 F. Hoffmann-La Roche AG: Segmental Revenue

Figure 21 F. Hoffmann-La Roche AG: Geographical Revenue

Figure 22 Illumina, Inc.: Key Financials

Figure 23 Illumina, Inc.: Segmental Revenue

Figure 24 Illumina, Inc.: Geographical Revenue

Figure 25 IGENOMIX: Key Financials

Figure 26 IGENOMIX: Segmental Revenue

Figure 27 IGENOMIX: Geographical Revenue

Figure 28 Reprogenetics, LLC: Key Financials

Figure 29 Reprogenetics, LLC: Segmental Revenue

Figure 30 Reprogenetics, LLC: Geographical Revenue

Figure 31 Genea Limited: Key Financials

Figure 32 Genea Limited: Segmental Revenue

Figure 33 Genea Limited: Geographical Revenue

Figure 34 PerkinElmer, Inc.: Key Financials

Figure 35 PerkinElmer, Inc.: Segmental Revenue

Figure 36 PerkinElmer, Inc.: Geographical Revenue

Figure 37 Genesis Genetics Ltd.: Key Financials

Figure 38 Genesis Genetics Ltd.: Segmental Revenue

Figure 39 Genesis Genetics Ltd.: Geographical Revenue

Figure 40 Quest Diagnostics Incorporated: Key Financials

Figure 41 Quest Diagnostics Incorporated: Segmental Revenue

Figure 42 Quest Diagnostics Incorporated: Geographical Revenue

Figure 43 Thermo Fisher Scientific, Inc: Key Financials

Figure 44 Thermo Fisher Scientific, Inc: Segmental Revenue

Figure 45 Thermo Fisher Scientific, Inc: Geographical Revenue

Figure 46 Bioarrayn Genetics: Key Financials

Figure 47 Bioarrayn Genetics: Segmental Revenue

Figure 48 Bioarrayn Genetics: Geographical Revenue

Figure 49 Laboratory Corporation of America Holdings: Key Financials

Figure 50 Laboratory Corporation of America Holdings: Segmental Revenue

Figure 51 Laboratory Corporation of America Holdings: Geographical Revenue

Figure 52 California Pacific Medical Center: Key Financials

Figure 53 California Pacific Medical Center: Segmental Revenue

Figure 54 California Pacific Medical Center: Geographical Revenue

Figure 55 Reproductive Health Science Ltd: Key Financials

Figure 56 Reproductive Health Science Ltd: Segmental Revenue

Figure 57 Reproductive Health Science Ltd: Geographical Revenue




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.